Antonio Vega-pacheco M.S., L.M.H.C.

Recommended Articles

• The Struggle of a Disabled Traveler Looking to Make a Living

  Richard Kuppusamy is a man who has to constantly travel for his work. Every 3 weeks, Kuppusamy boards a plane bound for whatever destination in order to earn a living. The only problem is: Richard suffers from a rare condition called spina bifida, a malformation of the spine that renders the patient...

• Chemotherapy for Multiple Sclerosis

  For those who suffer from multiple sclerosis, there are a lot of treatments available in managing the symptoms. However, there is no complete cure for this disease. The choice of multiple medications depends on person-to-person since every person’s body responds differently to each treatment....

• Alternative Treatments for Dehydration

  There is a situation in which body water content can decrease to a level below what is permissible. In such a case, the equilibrium of minerals in our usual bodily fluids is disturbed. This situation leads to dehydration, in which somebody loses fluids from the body excessively as compared to the...

• Taurine Reduces the Risk of Coronary Heart Disease in Women

  For women with high cholesterol, incorporating taurine into the diet can reduce the risk of heart diseases.According to the European Journal of Nutrition, it is revealed that taurine, the amino acid found in high amounts in poultry, meat, and in other food products, is highly useful and works as a...

• Sleep Apnea Linked to Death of Carrie Fisher and Other Little Known Facts About the Condition

  Everyone suddenly hears about the death of Princess Leia, Carrie Fisher. The media immediately starts to investigate the possible causes of celebrity deaths and does not always give us clear answers. Months later, the real causes of death are shown to audiences through press conferences where family...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...